SMA Research Platform

Evidence graph for Spinal Muscular Atrophy

Biology-first target discovery
Christian Fischer / Bryzant Labs
15,945Targets
453Trials
85Drugs
7Datasets
8,004Sources
221,721Claims
232,882Evidence
73,172Hypotheses
DRUGapprovedsmall molecule

Dimethyl Fumarate

Brand names: Tecfidera

Mechanism

NRF2 activator

Related claims (1)

TypePredicateConfSource
safetySulforaphane exhibits reduced systemic toxicity compared to dimethyl fumarate while being slightly less efficacious in methylmercury-induced ALS-like pathology.53%41649614

Off-Target Findings (0)

No Boltz-2 / Chai-1 off-target panel claims recorded for this drug.

Login → Command Center